Myasthenia Gravis

Myasthenia gravis is an autoimmune disorder that causes muscle weakness, often in the eyes, face, and throat.

Programs + Services


Thoracic Surgery

The Division of Thoracic Surgery at Tufts MC in Boston provides cutting-edge, patient-centered care for the wide range of thoracic disorders and diseases.
More information about programs and services


Neuromuscular Disorders Program

The Neuromuscular Disorders Program provides comprehensive care for the full spectrum of neuromuscular disorders and diseases, including ALS.
More information about programs and services

Doctors + Care Team

Mithila Vullaganti, MD

Mithila Vullaganti, MD

Accepting New Patients

Title(s): Neurologist; Assistant Professor, Tufts University School of Medicine
Department(s): Neurology
Appt. Phone: 617-636-5848
Fax #: 617-636-8199

Neuromuscular diseases, EMG

View Full Profile for Mithila Vullaganti, MD

Research + Clinical Trials


A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis

This is a phase 3, randomized, double-blind, placebo-controlled, multicenter study that evaluates using ravulizumab infusions as treatment for patients with generalized Myasthenia Gravis. Participants will receive either ravulizumab for the duration of the study or placebo during the 26-week randomized-controlled period of the stufy and then enter the open-label extension period where they will receive ravulizumab. The main outcome will look at the change from baseline in Myasthenia Gravis-Activities of Daily Living (MG-ADL) score at week 26 (end of randomized period).
More information about research and clinical trials